Gastrointestinal Therapeutics and Diagnostics - Technologies and Global Markets - Expected to Reach $63.8 Billion in 2021 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Gastrointestinal Therapeutics and Diagnostics: Technologies and Global Markets" report to their offering.

The global market for gastrointestinal disorder therapeutics and diagnostics reached $49.6 billion in 2015. This market is expected to grow from nearly $51.8 billion in 2016 to $63.8 billion in 2021 at a compound annual growth rate of 4.3% from 2016-2021.

The report provides a brief overview of the gastrointestinal system, which provides an introduction to the disorders of the gastrointestinal system; cites risk factors, where applicable; presents current pharmaceutical treatments, market size and key market participants (both prescription and OTC); and presents potential treatments in R&D, potential market size and future market entrants.

Scope of the Report:

  • An overview of the global markets for gastrointestinal therapeutics and diagnostics.
  • Analyses of global market trends, with data from 2015, estimates for 2016, and projections of CAGRs through 2021.
  • Analyses of therapeutics currently on the market as well as potential products and classes of products that are likely to have a significant impact.
  • Descriptions of the industry in detail, its relationship to the healthcare industry, its participants, and its trends for the future.
  • Evaluation of the market's dynamics, specifically growth drivers, restraints, and opportunities.
  • Profiles of major players in the industry.

Companies Mentioned:

  • Allergan Plc
  • Ardelyx Inc.
  • Astellas Pharma Inc.
  • AstraZeneca
  • Celgene Corp.
  • Clovis Oncology
  • Daewoong Pharmaceutical Co. Ltd.
  • Eli Lilly and Company
  • GlaxoSmithKline
  • Horizon Pharma Plc
  • ImmunogenX
  • Immunomedics
  • Merck & Co.
  • Merrimack Pharmaceuticals Inc.
  • New Link Genetics
  • Otsuka Holdings Co. Ltd.
  • Pfizer Inc.
  • Roche
  • Sanofi
  • Shire
  • Sucampo Pharmaceuticals Inc.
  • Synergy Pharmaceuticals Inc.
  • Synthetic Biologics
  • Taiho Pharmaceutical Co. Ltd.
  • Takeda Pharmaceuticals
  • Valeant Pharmaceuticals

Key Topics Covered:

1: Introduction - Complimentary

2: Executive Summary

3: Overview

4: Etiology

5: Prescription Therapy Market

6: OTC Therapy Market

7: Diagnostics And Devices Market

8: Gastrointestinal Product Pipeline

9: Patents

10: Company Profiles

For more information about this report visit http://www.researchandmarkets.com/research/l5lhfx/gastrointestinal.

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For EST Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Diagnostics, Gastrointestinal Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For EST Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Diagnostics, Gastrointestinal Drugs